DAVID M MOTT Insider Trading $MRSN Mersana Therapeutics, Inc.
Get free email notifications about insider trading for DAVID M MOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and Director in NOVAVAX INC ($NVAX) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and Director in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and Director in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and Director in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Epizyme, Inc. ($EPZM) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in IMARA Inc. ($IMRA) and 10% Owner in Elastic N.V. ($ESTC) and Director in Nightstar Therapeutics plc ($NITE) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM).
DAVID M MOTT in Mersana Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 9,109 shares
Latest Transaction: Jan 20 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID M MOTT in Mersana Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ADAP, APPN, ABIO, ARDX, AVEO, CRCM, CASC, CERC, ESTC, EPZM, GNCA, IMRA, ILIU, MEDI, MRSN, MIRM, MULE, NITE, NVAX, RARX, RGLS, RYTM, ROKA, SURF, SYBX, TSRO, TCON, TRVI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20 2021 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | A | 21.09 | 4,528 | 95,496 | 4,528 | |
| Dec 15 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | J | 0.00 | 486 | 0 | 9,595 | 9.1 K to 9.6 K (+5.34 %) |
| Dec 15 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | J | 0.00 | 1,096 | 0 | 9,109 | 8 K to 9.1 K (+13.68 %) |
| Nov 12 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | J | 0.00 | 1,112 | 0 | 6,400 | 5.3 K to 6.4 K (+21.03 %) |
| Nov 12 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | J | 0.00 | 496 | 0 | 5,288 | 4.8 K to 5.3 K (+10.35 %) |
| Nov 12 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | J | 0.00 | 496 | 0 | 4,792 | 4.3 K to 4.8 K (+11.55 %) |
| Nov 12 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | J | 0.00 | 1,106 | 0 | 4,296 | 3.2 K to 4.3 K (+34.67 %) |
| Jun 29 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | A | 22.90 | 9,200 | 210,680 | 9,200 | |
| Apr 13 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | J | 0.00 | 993 | 0 | 3,190 | 2.2 K to 3.2 K (+45.20 %) |
| Apr 13 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | J | 0.00 | 2,197 | 0 | 2,197 | 0 to 2.2 K |
| Apr 09 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | P | 5.59 | 538,599 | 3,010,768 | 538,599 | 0 to 538.6 K |
| Jan 03 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | A | 5.36 | 19,713 | 105,662 | 19,713 | |
| Jan 03 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | A | 5.36 | 19,713 | 105,662 | 19,713 | |
| Jun 11 2019 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | A | 4.31 | 25,000 | 107,750 | 25,000 | |
| Mar 06 2019 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | P | 4.00 | 3,750,000 | 15,000,000 | 11,890,138 | 8.1 M to 11.9 M (+46.07 %) |
| Jan 04 2019 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | A | 4.31 | 25,292 | 109,009 | 25,292 | |
| Sep 21 2018 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | A | 12.27 | 10,000 | 122,700 | 10,000 | |
| Jan 04 2018 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | A | 17.39 | 6,611 | 114,965 | 6,611 | |
| Jul 06 2017 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | C | 0.00 | 2,216,626 | 0 | 0 | |
| Jul 06 2017 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | C | 0.00 | 18,001,419 | 0 | 0 | |
| Jul 06 2017 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | C | 0.00 | 11,931,173 | 0 | 0 | |
| Jul 06 2017 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | P | 15.00 | 1,000,000 | 15,000,000 | 8,140,138 | 7.1 M to 8.1 M (+14.01 %) |
| Jul 06 2017 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | C | 0.00 | 7,140,138 | 0 | 7,140,138 | 0 to 7.1 M |
Page: 1